The plasmalemmal localization of CNKSR1 as well as colocalization with K-Ras mutant at the plasma membrane was lost by treatment of K-Ras mutated cancer cells with PHT-7.3 (Indarte et al, 2019). This evidence concerns the gene KRAS and cancer.